Clinical Trials Browser

Phase 2/3 × Temozolomide × Thoracic × Clear all

NCT03732482 2019-01-29

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Phase 2/3 Unknown

Non Small Cell Lung Cancer Metastatic

NCT02772107 2016-05-17

Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer

Phase 2/3 Unknown

Small Cell Lung Carcinoma